company background image
SBM logo

Sirona Biochem TSXV:SBM Stock Report

Last Price

CA$0.06

Market Cap

CA$15.8m

7D

0%

1Y

-14.3%

Updated

17 Mar, 2025

Data

Company Financials

Sirona Biochem Corp.

TSXV:SBM Stock Report

Market Cap: CA$15.8m

SBM Stock Overview

A cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. More details

SBM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Negative shareholders equity

Makes less than USD$1m in revenue (CA$-16K)

Has less than 1 year of cash runway

Highly volatile share price over the past 3 months compared to the Canadian market

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Sirona Biochem Corp. Competitors

Rakovina Therapeutics

TSXV:RKV

CA$17.5m

COSCIENS Biopharma

TSX:CSCI

CA$19.2m

BriaCell Therapeutics

TSX:BCT

CA$19.7m

Telo Genomics

TSXV:TELO

CA$11.0m

Price History & Performance

Summary of share price highs, lows and changes for Sirona Biochem
Historical stock prices
Current Share PriceCA$0.06
52 Week HighCA$0.095
52 Week LowCA$0.02
Beta-0.11
1 Month Change-7.69%
3 Month Change-14.29%
1 Year Change-14.29%
3 Year Change-70.73%
5 Year Change-75.51%
Change since IPO-45.45%

Recent News & Updates

Recent updates

Shareholder Returns

SBMCA BiotechsCA Market
7D0%0.4%0.4%
1Y-14.3%12.8%10.0%

Return vs Industry: SBM underperformed the Canadian Biotechs industry which returned 12.8% over the past year.

Return vs Market: SBM underperformed the Canadian Market which returned 10% over the past year.

Price Volatility

Is SBM's price volatile compared to industry and market?
SBM volatility
SBM Average Weekly Movement23.6%
Biotechs Industry Average Movement11.7%
Market Average Movement8.6%
10% most volatile stocks in CA Market17.5%
10% least volatile stocks in CA Market3.3%

Stable Share Price: SBM's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: SBM's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2006n/aHoward Verricowww.sironabiochem.com

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009.

Sirona Biochem Corp. Fundamentals Summary

How do Sirona Biochem's earnings and revenue compare to its market cap?
SBM fundamental statistics
Market capCA$15.82m
Earnings (TTM)-CA$2.67m
Revenue (TTM)n/a

-966.7x

P/S Ratio

-5.9x

P/E Ratio

Is SBM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SBM income statement (TTM)
Revenue-CA$16.36k
Cost of RevenueCA$65.13k
Gross Profit-CA$81.49k
Other ExpensesCA$2.58m
Earnings-CA$2.67m

Last Reported Earnings

Jul 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.01
Gross Margin498.01%
Net Profit Margin16,294.87%
Debt/Equity Ratio-95.8%

How did SBM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/17 09:51
End of Day Share Price 2025/03/05 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sirona Biochem Corp. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward AcklinFirst Berlin Equity Research GmbH
Jens HasselmeierFirst Berlin Equity Research GmbH